Pages that link to "Q37015519"

The following pages link to Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers (Q37015519):

Displaying 30 items.

• Cerebrospinal fluid analysis in the HIV infection and compartmentalization of HIV in the central nervous system (Q26801033) (← links)
• Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia (Q28475360) (← links)
• Raltegravir cerebrospinal fluid concentrations in HIV-1 infection (Q28476050) (← links)
• Amyloid and tau cerebrospinal fluid biomarkers in HIV infection (Q33520347) (← links)
• Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates (Q33686847) (← links)
• Evolving character of chronic central nervous system HIV infection (Q33995713) (← links)
• The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? (Q34113072) (← links)
• ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects (Q34202181) (← links)
• Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection (Q34776835) (← links)
• Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients (Q35093695) (← links)
• Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection (Q35219829) (← links)
• The cerebrospinal fluid proteome in HIV infection: change associated with disease severity (Q35965332) (← links)
• Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study (Q35996619) (← links)
• Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment (Q36050420) (← links)
• Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid. (Q36072424) (← links)
• 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder (Q36507182) (← links)
• Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches (Q36530897) (← links)
• Antiretroviral therapy and central nervous system HIV type 1 infection (Q37066982) (← links)
• Biomarkers of HIV related central nervous system disease (Q37073672) (← links)
• Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration (Q37141166) (← links)
• YKL-40: a candidate biomarker for simian immunodeficiency virus and human immunodeficiency virus encephalitis? (Q37201215) (← links)
• HIV-related neurocognitive impairment in the HAART era. (Q37546230) (← links)
• Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection (Q38128778) (← links)
• Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond. (Q38208168) (← links)
• Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND) (Q38258410) (← links)
• Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls (Q38734471) (← links)
• Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy. (Q40478740) (← links)
• Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system (Q41002594) (← links)
• Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection (Q41978842) (← links)
• Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study (Q92823185) (← links)